Recently, the European League against Rheumatism (EULAR) released updated research-based recommendations for treating all aspects of systemic scleroderma. It is freely available online here: http://ard.bmj.com/content/early/2017/04/25/annrheumdis-2016-209909?papetoc. While this is a very technical article, most of it is actually pretty easy to understand as long as you are not intimated by the heavy use of abbreviations, universal in published medical research papers.
A couple of helpful suggestions: if you see an abbreviation that you don’t understand, e.g., RCT (randomized controlled trial), it will always be defined earlier in the document, the first time it is used. Also, unless you have a statistical background, just skim over the detailed statistical analysis and focus on the text.